Drug-eluting stents are safe and effective: Right or wrong?

Journal of the American College of Cardiology

Volumn 47, Issue 7, 2006, Pages 1361-1362

  Sigwart, Ulrich ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b University Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; HUMAN; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 33645411645     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.02.001     Document Type: Editorial

References (12)

1. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, L. Kappenberger Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 316 1987 701 706
2. P.C. Block Coronary-artery stents and other endoluminal devices N Engl J Med 324 1991 52 53
3. M.B. Leon, D.S. Baim, J.J. Popma Stent Anticoagulation Restenosis Study Investigators A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting N Engl J Med 339 1998 1665 1671
4. V. Verin, Y. Popowski, B. de Bruyne Dose-Finding Study Group The Dose-Finding Study Group Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty N Engl J Med 344 2001 243 249
5. M. Sabate, P.W. Serruys, W.J. van der Giessen Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy a three-dimensional intravascular ultrasound study Circulation 10 1999 1182 1188
6. M.C. Morice, P.W. Serruys, J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
7. J. Fajadet, M.C. Morice, C. Bode Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents three-year results of the RAVEL trial Circulation 111 2005 1040 1044
8. A.T.L. Ong, R.T. van Domburg, J. Aoki Sirolimus-eluting stents remain superior to bare metal stents at two years medium term results from the RESEARCH registry J Am Coll Cardiol 47 2006 1356 1360
9. G. Weisz, M.B. Leon, D.R. Holmes Jr Two-year outcomes after sirolimus-eluting stent implantation results from the SIRIUS trial J Am Coll Cardiol 47 2006 1350 1355
10. J.E. Sousa, M.C. Morice, P.W. Serruys A randomised, double-blind study with the sirolimus eluting Bx-Velocity balloon expandable stent in the treatment of patients with de novo native coronary artery lesions clinical follow up at 4 years 2005 Presented at: EuroPCR, Paris, May
11. I. Iakovou, T. Schmidt, E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
12. R. Virmani, G. Guagliumi, A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 109 2004 701 705